Interesting report from Cannabiz illustrating what is already common knowledge globally by ressearchers.
We presume even an Australian study with published results like this won’t stop the Victorian Government wasting $AUS5 Million with Swinburne!
Australian researchers have found insomnia patients using medicinal cannabis containing THC experience little or no next-day impairment in findings which could have a significant impact on the debate around drug-driving reform.
The team, including representatives from the Woolcock Institute of Medical Research and the Lambert Initiative for Cannabinoid Therapeutics, studied 20 adults with insomnia to determine next-day impairment following evening administration of a typical medicinal cannabis oil compared to a placebo.
Read the full report
